ONO 4057

Drug Profile

ONO 4057

Alternative Names: LB 457; ONO-4057

Latest Information Update: 01 Jun 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Class Anti-inflammatories; Antipsoriatics; Phenylpropionates
  • Mechanism of Action Leukotriene B4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Behcet's syndrome; Gastritis; Ulcerative colitis

Most Recent Events

  • 01 Jun 2011 Discontinued - Phase-II for Behcet's syndrome in Japan (PO)
  • 01 Jun 2011 Discontinued - Phase-II for Ulcerative colitis in Japan (PO)
  • 01 Jun 2011 Discontinued - Preclinical for Gastritis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top